CANCER 2026 , ,
Presentations this author is a contributor to:
Co-targeting thrombospondin-1 (THBS-1) to improve KRAS inhibitor and chemotherapeutic efficacy in pancreatic cancer (#268)
5:35 PM
Victoria M Tyma
Poster Session 2
Identifying and targeting FOLFIRINOX resistance mechanisms to improve outcomes in pancreatic cancer (#153)
5:40 PM
Katie Gordon
Welcome Reception & Poster Session 1
Temporally resolved proteomics identifies nidogen-2 as a co-target in pancreatic cancer that modulates fibrosis and therapy response (#235)
5:35 PM
Brooke Pereira
Poster Session 2
Pancreatic cancer secretome reveals PCSK9 as a co-target to sensitise tumours to chemotherapy and reduce metastasis (#244)
5:35 PM
Shona Ritchie
Poster Session 2
Identifying and targeting treatment response mechanisms to improve Gemcitabine/Abraxane performance in Patient-Derived Models of Pancreatic Cancer (#263)
5:35 PM
Alice Tran
Poster Session 2